Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Gan To Kagaku Ryoho ; 45(4): 691-693, 2018 Apr.
Article in Japanese | MEDLINE | ID: mdl-29650837

ABSTRACT

A 90-year-old female patient was admitted to our hospital with a chief complaint of vomiting.Gastroscopy revealed type 3 gastric cancer and gastric outlet obstruction(GOO).Abdominal computed tomography revealed thickening of the antral wall and suggested the presence of 3 perigastric lymph node metastases, but there was no ascitic fluid or distant metastasis.The clinical diagnosis was T4a(SE)N2H0CYXP0M0, Stage III B, according to the Japanese Classification of Gastric Carcinoma.Her general conditions including kidney and cardiac function were good, we considered that she was able to tolerate radical distal gastrectomy.We planned laparoscopic distal gastrectomy(LDG)and D2 lymphadenectomy after getting sufficient informed consent.The patient experienced an uneventful post-operative recovery, and was discharged in good health 11 days after surgery.


Subject(s)
Gastric Outlet Obstruction/surgery , Stomach Neoplasms/surgery , Aged, 80 and over , Female , Gastrectomy/methods , Gastric Outlet Obstruction/etiology , Humans , Laparoscopy , Lymphatic Metastasis , Stomach Neoplasms/complications , Stomach Neoplasms/pathology , Treatment Outcome
2.
Gan To Kagaku Ryoho ; 45(13): 2093-2095, 2018 Dec.
Article in Japanese | MEDLINE | ID: mdl-30692295

ABSTRACT

An 87-year-old male patient was admitted to our hospital with a chief complaint of vomiting. Gastroscopy revealed Type 0-Ⅱc+Ⅱa tumor at the posterior wall in the middle third of the stomach. A biopsy indicated moderately differentiated adenocarcinoma. Abdominal CT revealed no lymph node or distant metastases. The clinical diagnosis was cT2(MP), N0, M0, cStage Ⅰ. Laparoscopic distal gastrectomy with D2 lymphadenectomy was performed. The pathological findings revealed moderately differentiated adenocarcinoma containing synaptophysin, chromogranin A, and CD56-positive tumor cells. He was then diagnosed with adenocarcinoma with neuroendocrine differentiation. The pathological diagnosis was pT2(MP), pN0, M0, pStage ⅠB. MRI revealed multiple liver metastases 5 months postoperatively. S-1 alone chemotherapy was started, and the patient showed partial response(PR)after 3 courses, according to the Response Evaluation Criteria in Solid Tumor (RECIST).


Subject(s)
Adenocarcinoma , Liver Neoplasms , Stomach Neoplasms , Adenocarcinoma/secondary , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Differentiation , Gastrectomy , Humans , Liver Neoplasms/secondary , Male , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery
3.
Gan To Kagaku Ryoho ; 44(12): 1443-1445, 2017 Nov.
Article in Japanese | MEDLINE | ID: mdl-29394662

ABSTRACT

The patient was a 64-year-old man with esophagogastric junction cancer. We performed right thoracotomy-laparotomy for lower esophageal and cardiac gastric resection, D2 lymphadenectomy, and reconstruction of a gastric tube in October 2011. Histopathology confirmed T4aN1M1(LYM), Stage IV cancer(Japanese Classification of Gastric Carcinoma, 14th edition) with R0 resection. Because of preexisting alcoholic cirrhosis, postoperative chemotherapy was not an option. In March 2014, we performed left adrenalectomy for left adrenal metastasis, and in December 2014, we performed right adrenalectomy for metastasis to the right adrenal gland. The patient was prescribed 20mg/day of hydrocortisone postoperatively. Survival from the right adrenalectomy was 2 years and 2 months, and survival from the first operation was 5 years and 4 months, without recurrence. This case of esophagogastric junction cancer resection with bilateral adrenal metastasis is rare, with only one previously reported case in Japan.


Subject(s)
Adrenal Gland Neoplasms/surgery , Adrenalectomy , Esophagogastric Junction/pathology , Stomach Neoplasms/pathology , Adrenal Gland Neoplasms/secondary , Esophagogastric Junction/surgery , Gastrectomy , Humans , Male , Middle Aged , Recurrence , Stomach Neoplasms/surgery
4.
J Anus Rectum Colon ; 6(3): 181-189, 2022.
Article in English | MEDLINE | ID: mdl-35979275

ABSTRACT

Objectives: The cornerstone of treating colorectal cancer (CRC) is generally a surgical resection with lymph node (LN) dissection. The tools for predicting lymph node metastasis (LNM) in submucosal (SM) CRC are useful to avoid unnecessary surgical resection. Methods: Retrospectively, we analyzed 526 consecutive patients with SM CRC who underwent surgical resection at the Osaka International Cancer Institute, Osaka University Hospital, and Minoh City Hospital, Japan, between 1984 and 2012. The Osaka International Cancer Institute group and the Osaka University Hospital group were randomly divided into a training set and a test set of 2:1. The prediction model was validated in Minoh City Hospital. Results: We partitioned patients using three risk factors involved in the presence or absence of LNM in SM CRC: lymphatic invasion (Ly), budding grade (BD) and the depth of submucosal invasion (DSI) (cut-off value 2789 µm) that were significantly different in the multivariate analysis. As a result, a predictive model of "LNM <5%" when "Ly negative and DSI <2789 µm" was evaluated. We similarly partitioned by DSI 3000 µm as easy-to-evaluate values in clinical use. We developed the additional model for predicting LNM is 1.05%, that is, LNM <5%, when there are "Ly negative and DSI <3000 µm." Conclusions: As a limitation, only patients who underwent surgical resection were included in this study. This predictive model could help clinicians and CRC patients decide on the additional surgery required after endoscopic resection.

SELECTION OF CITATIONS
SEARCH DETAIL